Abstract
Extracts from saffron, the dried stigmata from Crocus sativus L., are being used more and more in preclinical and clinical trials for the treatment of cancer and depression. Because of the known quality problems of saffron, HPLC methods on RP18 2.5 μm and monolithic RP18 material have been developed and validated for quality control including the quantification of crocins 1 to 5, crocetin, picrocrocin and the degradation products, the cis -crocins. Additionally, a GC-MS method has allowed detection and quantification of the volatile compounds from the pentane extract of saffron. Both systems together allowed the comprehensive characterisation of saffron herbal material and extracts for clinical/preclinical trials. For effective preparation of the respective reference standards, a fast centrifugal partition chromatography (FCPC) method was developed allowing the quick isolation of crocins 1, 2, 5 and picrocrocin in good yields. Using these chromatographic methods and the reference standards, a representative survey of saffron from the global market indicated a high variability of quality, especially concerning the amounts of volatile compounds in saffron samples. A specification for high-quality saffron of > 20 % crocins, > 6 % picrocrocin and not less than 0.3 % of volatiles, calculated as sum of safranal, isophorone and ketoisophorone, was developed. Because no detailed pharmacological studies are available to explain the clinical effects of saffron for the treatment of cancer and depression, receptor binding studies were performed. Saffron extracts and crocetin had a clear binding capacity at the PCP binding side of the NMDA receptor and at the σ1 receptor, while the crocins and picrocrocin were not effective. These data could give biochemical support for the above-mentioned pharmacological effects of saffron.
Key words
Crocus sativus L. - Iridaceae - saffron - NMDA receptor - σ1 (sigma-1) receptor - crocins
References
Crocus . In: Blaschek W, Ebel S, Hackenthal E, Holzgrabe U, Seller U, Reichling J, editors HagerRom: Hagers Handbuch der Drogen und Arzneistoffe . Heidelberg (Germany); Thieme Publishers 2006, Springer Electronic Media
Saffron. Crocus sativus . Amsterdam; Harwood Academic Publishers 2005: 103-13
Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial.
Phytother Res.
2005;
19
148-51
Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial.
J Ethnopharmacol.
2005;
97
281-4
Crocus sativus stigmas and Gardenia jasminoides fruits. Tentative identification of seven new compounds by LC-ESI-MS.
J Agric Food Chem.
2006;
54
973-9
http://www.fda.gov/cder/guidance/ichq2a.pdf . Accessed March 06, 2008.
http://www.fda.gov/cder/guidance/1320fnl.pdf . Accessed March 06, 2008.
Crocus sativus L.).
J Agric Food Chem.
1998;
46
3238-43
Natural product analysis: chromatography - spectroscopy - biological testing, 1st. edition . Wiesbaden; Vieweg Publishers 1998: 27-34
ahensel@uni-muenster.de
